Author

Nicholas France

Observed institution: Roivant Sciences (United States)

OpenAlex ID: A5110664101

An open‐label study to determine the pharmacokinetics and safety of migalastat HCl in subjects with impaired renal function and healthy subjects with normal renal function

2014 · Franklin K. Johnson, Paul N. Mudd, et al. · Clinical Pharmacology in Drug Development · 14

[p3–017]: Headway‐dlb: a Multinational Study Evaluating the Safety and Efficacy of Intepirdine (rvt‐101) in Dementia With Lewy Bodies

2017 · Ian G. McKeith, Dag Aarsland, et al. · Alzheimer s & Dementia · 6

Phase 3 FACETS study of migalastat HCl for Fabry disease: post hoc GLA mutation-based identification of subjects likely to show a drug effect

2014 · Carrolee Barlow, Jeff Castelli, et al. · Molecular Genetics and Metabolism · 2

Sphingosine-1-phosphate receptor type 5 (S1P5) agonism: A potential new mechanism for the treatment of neuronopathic features of Niemann-Pick disease type C and neurodegenerative sphingolipidoses

2020 · Nicholas France, Enchi Liu, et al. · Molecular Genetics and Metabolism · 1

Medicine in the 21st Century

2020 · Nicholas France, Bruno Rushforth, et al. · McGill Journal of Medicine

Works count: 5

Citation count: 23

H-index: 2

I10-index: 1